 | Up a level |
2017
Cornely, Oliver A. 
ORCID: 0000-0001-9599-3137, Leguay, Thibaut, Maertens, Johan ORCID: 0000-0003-4257-5980, Vehreschild, Maria J. G. T. ORCID: 0000-0003-0446-3224, Anagnostopoulos, Achilles ORCID: 0000-0003-4384-9031, Castagnola, Carlo, Verga, Luisa, Rieger, Christina, Kondakci, Mustafa, Harter, Georg ORCID: 0000-0001-9946-6246, Duarte, Rafael F., Allione, Bernardino, Cordonnier, Catherine, Heussel, Claus Peter ORCID: 0000-0001-5809-5733, Morrissey, C. Orla ORCID: 0000-0002-9970-9575, Agrawal, Samir G., Donnelly, J. Peter ORCID: 0000-0002-8521-335X, Bresnik, Mark, Hawkins, Michael J., Garner, Will ORCID: 0000-0003-0738-8696, Goekbuget, Nicola and Fätkenheuer, Gerd ORCID: 0000-0002-5054-1871
(2017).
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.
J. Antimicrob. Chemother., 72 (8).
S. 2359 - 2368.
OXFORD UNIV PRESS.
ISSN 1460-2091
2014
Cornely, Oliver, Leguay, Thibaut, Maertens, Johan, Castagnola, Carlo, Anagnostopoulos, Achilles, Allione, Bernadino, Heussel, Claus Peter, Donnelly, J. Peter, Agrawal, Samir G., Garner, Will, Simcock, Catherine, Hawkins, Michael J. and Goekbuget, Nicola (2014). A Double-Blind, Multicentre, Randomised, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome (R)) for the Prevention of Invasive Fungal Infections in Subjects Receiving Remission-Induction Chemotherapy for Acute Lymphoblastic Leukaemia (AmBiGuard trial). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020